Ultromics
PrivateLast Round
Series C
Jul 31, 2025
Est. Valuation
$300M
Total Funding Raised
$159M
Company Overview
Ultromics is a health tech company that provides an AI-powered cardiovascular diagnostic platform, EchoGo, to analyze echocardiograms for the early and more accurate detection of heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ultromics Comps
Public and private peers based on sector, stage, and business model.
Ultromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 31, 2025 | ||||
| Series C | Jul 31, 2024 | ||||
| Series B | Aug 16, 2021 | ||||
| VC Round | Jun 16, 2020 | ||||
| Series A | May 23, 2018 | ||||
Seed | May 1, 2017 |
Key People
Founding team and executive leadership
Ultromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCM Ventures | Series C |
| Nina Capital | VC Round |
| GV | Series B, Series C |
| Legal & General Group | Series C |
| Oxford Science Enterprises | VC Round, Series B, Series C, Series A, Seed |
| Tanarra | Series A |
| University of Oxford | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Achieved Category III CPT reimbursement from the Centers for Medicare & Medicaid Services.
- Feb 23, 2026
Spun out from the University of Oxford.
Ultromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ultromics's valuation, stock price, and market status.
